Commentary
THE ROUND OF 16 RESULTS: AI, CONSUMERS, EMPLOYERS AND DRUG COSTS DEFINE THE BRACKET
The bracket has narrowed, and the stakes are rising. The Round of 16 marks the point where strong ideas turn into serious contenders: no more coasting on early momentum or favorable matchups. Across the Providers, Purchasers & Plans, Policy and Pioneers regions, 16 trends take the floor with a shot at the Round of 8, each bringing a distinct case for why it will shape healthcare in 2026. Every matchup presents a clash of priorities, pressures and possibilities. Now, it’s time to see which trends can execute on the hardwood!
Explore the interactive bracket and join the weekly tournament on our LinkedIn page, where your vote helps choose the winner!
THE PROVIDERS REGION
AI Becomes the New Clinical Infrastructure Outlasts Workforce Challenges Reshape Care Delivery
As predicted by nearly every expert analyst, AI Becomes the New Clinical Infrastructure (1) continues its march toward the championship in the Round of 16, defeating Workforce Challenges Reshape Care (5) in a close game. Workforce challenges have been reshaping care delivery for many years, and although this will continue, it may not have as revolutionary an impact on healthcare in 2026 that AI will. Make way for AI as it forges ahead to the Round of 8!
“AI WILL INFILTRATE ALL ASPECTS OF HEALTHCARE. WHO DOESN’T CHECK WITH CHATGPT BEFORE THEY SEE THEIR DOCTOR?”
The Aging Demand Crunch Bullies Cybersecurity as a Clinical Priority
Cybersecurity issues have made their way past the front office and are directly impacting patient care, but against a team of nothing but seven-footers, this trend had no shots, no plays. Baby boomers have reached the most expensive age of healthcare utilization, and healthcare is feeling it. In a hard-to-watch game of slam dunk after slam dunk, The Aging Demand Crunch (6) makes quick work of Cybersecurity as a Clinical Priority (7).
“LAST YEAR, UTILIZATION WAS THE LEADING DRIVER OF INCREASED COSTS. THE FACT IS, BABY BOOMERS ARE GETTING REALLY OLD, AND THAT IS HAVING A TREMENDOUS IMPACT ON THE PROVIDER SIDE.”
THE PURCHASERS & PLANS REGION
Employers Rewrite the Benefits Playbook Overpowers Consumerization of Healthcare Demand
This was close matchup of teams with exquisite deployment of the backdoor cut, a tool both employers and consumers have sharpened to get around untenable healthcare costs. Had there been more time on the clock, Consumerization of Healthcare Demand (4) might have taken the win, but fortunately for Employers Rewrite the Benefits Playbook (1), the buzzer sounded before consumers could take another shot. The number one seed in the Purchasers & Plans region moves on to the Round of 8!
“EMPLOYERS ARE DEEPLY FRUSTRATED, DEEPLY CONCERNED ABOUT RISING HEALTHCARE COSTS. TEN PERCENT ANNUAL INCREASES ARE NOT SUSTAINABLE FOR A SMALL BUSINESS.”
Rx Cost Control Intensifies Halts Acceleration of Direct Contracting
What a disappointment for Acceleration of Direct Contracting (6)! This all-star fan favorite has never made it past the Round of 16 despite appearing in every tournament, and it sounds and looks like the same old song and dance for them this year. Rx Cost Control Intensifies (2) showed up with a clear game plan and used its size and strength to control the paint, deliver a suffocating defense and comfortably advance to the Round of 8.
“WE’RE GOING TO SEE A RADICALLY DIFFERENT WAY OF PAYING FOR DRUGS IN THE COMMERCIAL MARKET FIVE YEARS FROM NOW, AND 2026 IS THE YEAR THIS WILL REALLY KICK OFF.”
THE POLICY REGION
Price Transparency Enforcement Dumps OBBBA Rewrites Individual Coverage Rules
In this nuclear meltdown, Price Transparency Enforcement (4) took out its regional leader – OBBBA Rewrites Individual Coverage Rules (1) – in a smackdown that made fans question the seeding committee’s top choice. The gathering energy behind long-hyped cost benefits of price transparency rules passed in 2021 absolutely exploded on the court during this game, leaving no question about the impact the industry expects from this trend. See you in the Round of 8, price transparency!
“THIS ADMINISTRATION IS TAKING PRICE TRANSPARENCY ENFORCEMENT SERIOUSLY, AND I THINK THEY’RE WILLING TO PULL OUT THE HAMMER.”
Drug Pricing Shakeup Rattles Telehealth at a Crossroads
This contest sends a second pharma cost contender to the Round of 8 – a clear signal of just how dominant drug pricing has become. Telehealth is always a compelling team, known for its efficient, streamlined approach to care delivery, but this felt like a reset year for Telehealth at a Crossroads (3). It simply couldn’t absorb the physicality and sustained pressure from Drug Pricing Shakeup (2), which dictated terms throughout, never let up and sails easily forward.
“DRUG PRICING HAS BEEN A MASSIVE DRAG ON MEDICAL EXPENSE FOR THE FEDERAL GOVERNMENT AND FOR EMPLOYERS.”
THE PIONEERS REGION
Next-Gen Chronic Care Topples The Health Tech ROI Reckoning
Bracket-buster alert! The five-seed Next-Gen Chronic Care (5) came in ready for a fight and delivered, knocking off top-seeded The Health Tech ROI Reckoning (1) in one of the most physical, hard-fought matchups of the round. Fueled by the collision of aging-driven demand, AI-enabled care models and shifting federal priorities, this team showed up much more dangerous than its seed suggests. Voters made it clear: This is the year chronic care finally gets the respect it deserves.
“NEXT-GEN CHRONIC CARE IS AN AREA WE HAVEN’T GOTTEN RIGHT, AND THE OPPORTUNITY NOW IS HUGE, PARTICULARLY GIVEN HOW FOCUSED THE ADMINISTRATION IS ON IT.”
Consumers Take Health Optimization Direct Outplays AI Powers Drug Discovery
AI is arguably the bluest of the March Healthcare Classic bluebloods, but in this contest, it hit a brick wall. In a surprising turn, Consumers Take Health Optimization Direct (6) dissected AI Powers Drug Discovery (2) with surgical precision. Using the power of a direct-to-consumer diagnostics market projected to reach $6.8 billion by 2032, consumers deployed a masterful pick-and-roll strategy that kept AI off balance all game long. While generative AI is fueling the next wave of breakthroughs, much of that momentum is being driven by increasingly engaged, empowered patients.